...Health info at your doorstep

Day: 4 September 2020

Africa to Get 220 Million Covid-19 Vaccine Doses

Africa to Get 220 Million Covid-19 Vaccine Doses

Coronavirus, NEWS
The World Health Organization (WHO) has said that once a Covid-19 vaccine is approved, Africa will get at least 220 million initial doses. The first batch will prioritise front-line healthcare workers and vulnerable groups, according to the WHO Africa Program Area Manager Richard Mihigo. He said distribution will be based on the population of each country. Mr Mihigo said all 54 countries had expressed interest in a Covid-19 vaccine. Africa has a population of more than 1.3 billion people. The global vaccine initiative, called COVAX, intends to help purchase and fairly distribute 2 billion doses of approved vaccines by the end of 2021. The initiative has nine vaccine candidates that are being tested globally. Two of the vaccine candidates are currently being tested in A...
Doctors to Begin Indefinite Strike Monday

Doctors to Begin Indefinite Strike Monday

NEWS
The Nigerian Association of Resident Doctors will commence an indefinite nationwide strike next Monday. The National President of the association, Dr. Aliyu Sokomba, in a communique issued at the end of the virtual National Executive Council meeting of the association, held on Wednesday said the strike would continue until its demands were met. In the communique made available to PUNCH HealthWise on Friday, the association noted that the National Executive Council met on September 2, 2020, to review the 21-day ultimatum issued to the government which elapsed 17th of August 2020 and resolved to proceed on indefinite nationwide strike action from Monday 7th of September 2020 by 8:00 am until their demands are met. The communique stated that NEC observed that despite the inclus
Pharmaceutical Companies Vow not to ‘Cut Corners’ in Vaccine Race

Pharmaceutical Companies Vow not to ‘Cut Corners’ in Vaccine Race

Coronavirus, NEWS
Pharmaceutical company executives insisted on Thursday that they would not try to bring COVID-19 vaccines or treatments until they meet rigorous safety and efficiency standards. Across the world, governments are hoping to announce a vaccine as soon as possible and roll out treatments for the novel coronavirus, which has killed more than 860,000 people and infected over 26 million. But the sense of urgency has raised fears that companies and regulators might rush through testing meant to ensure that vaccines or treatments can be used safely and will actually be effective against the disease. “We will not cut corners,” Pfizer chief Albert Bourla told reporters in a virtual briefing. Pfizer and its partner BioNTech hope to wrap up final-stage Phase III trials of their COVID-
UK Study says Hydrocortisone helps Sickest COVID-19 Patients

UK Study says Hydrocortisone helps Sickest COVID-19 Patients

Coronavirus, NEWS
A commonly available anti-inflammatory drug, hydrocortisone, may help reduce the mortality rate of the sickest COVID-19 patients by 20 per cent, researchers said on Thursday. Professor Anthony Gordon, of Imperial College London, was part of a British team investigating the effectiveness of hydrocortisone on people on ventilators in intensive care. The results of the UK study were compared with those of six others around the world also looking at whether similar corticosteroid drugs could be used in treatment. “Taking the data from all the seven trials combined, in the patients who weren’t treated with steroids, about 40 per cent died from this severe COVID-19,” Gordon said. “In the groups that were given the various steroids, 32 per cent, roughly, died, so that’s a 20
Council Warns Against Importing Nasal Sprays from Ferring Pharmaceuticals

Council Warns Against Importing Nasal Sprays from Ferring Pharmaceuticals

NEWS
The Pharmacists Council of Nigeria has warned pharmaceutical importers against importing three nasal sprays from Ferring Pharmaceuticals, United States. The PCN also warned pharmacy owners against stocking the products. The PCN gave the directive in its September circular to pharmacists across the country. The affected products are DDAVP Nasal Spray 10mcg/0.1ml, Desmopressin Acetate Nasal Spray 10mcg/0.1ml and Stimate Nasal Spray 1.5ml. DDAVP Nasal Spray and Desmopressin Acetate Nasal Spray are used as antidiuretic replacement therapy in the management of central cranial diabetes insipidus, temporary polyuria and polydipsia, following head trauma or surgery in the pituitary region. Stimate Nasal Spray, on the other hand, is used for the treatment of patients with haemophilia...